Zobrazeno 1 - 10
of 119
pro vyhledávání: '"Fissette, K."'
Autor:
Ngabonziza, J.C.S., Loiseau, C., Marceau, M., Jouet, A., Menardo, F., Tzfadia, O., Antoine, R., Niyigena, E.B., Mulders, W., Fissette, K., Diels, M., Gaudin, C., Duthoy, S., Ssengooba, W., André, E., Kaswa, M.K., Habimana, Y.M., Brites, D., Affolabi, D., Mazarati, J.B., de Jong, B.C., Rigouts, L., Gagneux, S., Meehan, Conor J., Supply, P.
Yes
The human- and animal-adapted lineages of the Mycobacterium tuberculosis complex (MTBC) are thought to have expanded from a common progenitor in Africa. However, the molecular events that accompanied this emergence remain largely unknown. He
The human- and animal-adapted lineages of the Mycobacterium tuberculosis complex (MTBC) are thought to have expanded from a common progenitor in Africa. However, the molecular events that accompanied this emergence remain largely unknown. He
Externí odkaz:
http://hdl.handle.net/10454/18530
Autor:
Ngabonziza, J.-C.S., Habimana, Y.M., Decroo, T., Migambi, P., Dushime, A., Mazarati, J.B., Rigouts, L., Affolabi, D., Ivan, E., Meehan, Conor J., Van Deun, A., Fissette, K., Habiyambere, I., Nyaruhirira, A.U., Turate, I., Semahore, J.M., Ndjeka, N., Muvunyi, C.M., Condo, J.U., Gasana, M., Hasker, E., Torrea, G., de Jong, B.C.
Yes
SETTING: In 2005, in response to the increasing prevalence of rifampicin-resistant tuberculosis (RR-TB) and poor treatment outcomes, Rwanda initiated the programmatic management of RR-TB, including expanded access to systematic rifampicin dr
SETTING: In 2005, in response to the increasing prevalence of rifampicin-resistant tuberculosis (RR-TB) and poor treatment outcomes, Rwanda initiated the programmatic management of RR-TB, including expanded access to systematic rifampicin dr
Externí odkaz:
http://hdl.handle.net/10454/17785
Autor:
Lempens, P., Meehan, Conor J., Vandelannoote, K., Fissette, K., de Rijk, P., Van Deun, A., Rigouts, L., de Jong, B.C.
Yes
The majority of Mycobacterium tuberculosis isolates resistant to isoniazid harbour a mutation in katG. Since these mutations cause a wide range of minimum inhibitory concentrations (MICs), largely below the serum level reached with higher do
The majority of Mycobacterium tuberculosis isolates resistant to isoniazid harbour a mutation in katG. Since these mutations cause a wide range of minimum inhibitory concentrations (MICs), largely below the serum level reached with higher do
Externí odkaz:
http://hdl.handle.net/10454/17278
Autor:
Ofori-Anyinam, B., Dolganov, G., Van, T., Davis, J.L., Walter, N.D., Garcia, B.J., Voskuil, M., Fissette, K., Diels, M., Driesen, M., Meehan, Conor J., Yeboah-Manu, D., Coscolla, M., Gagneux, S., Antonio, M., Schoolnik, G., Gehre, F., de Jong, B.C.
Yes
Mycobacterium africanum lineage (L) 6 is an important pathogen in West Africa, causing up to 40% of pulmonary tuberculosis (TB). The biology underlying the clinical differences between M. africanum and M. tuberculosis sensu stricto remains p
Mycobacterium africanum lineage (L) 6 is an important pathogen in West Africa, causing up to 40% of pulmonary tuberculosis (TB). The biology underlying the clinical differences between M. africanum and M. tuberculosis sensu stricto remains p
Externí odkaz:
http://hdl.handle.net/10454/17574
Autor:
Rigouts, L., Coeck, N., Gumusboga, M., de Rijk, W.B., Aung, K.J., Hossain, M.A., Fissette, K., Rieder, H.L., Meehan, Conor J., de Jong, B.C., Van Deun, A.
Yes
Mutations in the gyrase genes cause fluoroquinolone resistance in Mycobacterium tuberculosis. However, the predictive value of these markers for clinical outcomes in patients with MDR-TB is unknown to date. The objective of this study was to
Mutations in the gyrase genes cause fluoroquinolone resistance in Mycobacterium tuberculosis. However, the predictive value of these markers for clinical outcomes in patients with MDR-TB is unknown to date. The objective of this study was to
Externí odkaz:
http://hdl.handle.net/10454/17328
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
The International Journal of Tuberculosis and Lung Disease; Vol 16
It currently takes 2-3 months to obtain a diagnosis for multidrug-resistant (MDR-) and extensively drug-resistant tuberculosis (XDR-TB). We evaluated the rapid non-commercial nitrate reductase assay (NRA), which is capable of the simultaneous detecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::73ca0eb30eb3970dc228ae51e15d5e1a
http://www.ncbi.nlm.nih.gov/pubmed/22236855
http://www.ncbi.nlm.nih.gov/pubmed/22236855